A New Perspective for the Treatment of Alzheimer’s Disease: Exosome-like Liposomes to Deliver Natural Compounds and RNA Therapies
Molecules · 11.08.2023 · 28 (16) · 6015
DOI: 10.3390/molecules28166015 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 11.08.2023. Verfasst von Joana Ribeiro und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Molecular and Environmental Biology (CBMA)/Aquatic Research Network (ARNET) Associate Laboratory, Universidade do Minho, Campus de Gualtar,…. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, Exosomes, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, Direção Regional da Ciência e Tecnologia, Governo Regional dos Açores, strategic program UID/BIA/04050/2020 funded by National funds through the Fundação para a Ciência e Tecnologia I.P..
Themen: Demenz
Abstract (Originalsprache)
With the increment of the aging population in recent years, neurodegenerative diseases exert a major global disease burden, essentially as a result of the lack of treatments that stop the disease progression. Alzheimer’s Disease (AD) is an example of a neurodegenerative disease that affects millions of people globally, with no effective treatment. Natural compounds have emerged as a viable therapy to fill a huge gap in AD management, and in recent years, mostly fueled by the COVID-19 pandemic, RNA-based therapeutics have become a hot topic in the treatment of several diseases. Treatments of AD face significant limitations due to the complex and interconnected pathways that lead to their hallmarks and also due to the necessity to cross the blood–brain barrier. Nanotechnology has contributed to surpassing this bottleneck in the treatment of AD by promoting safe and enhanced drug delivery to the brain. In particular, exosome-like nanoparticles, a hybrid delivery system combining exosomes and liposomes’ advantageous features, are demonstrating great potential in the treatment of central nervous system diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre of Molecular and Environmental Biology (CBMA)/Aquatic Research Network (ARNET) Associate Laboratory, Universidade do Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
- Institute of Science and Innovation for Sustainability (IB-S), Universidade do Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
ORCID-Profile: Joana Ribeiro, Ivo Lopes, Andreia Castro Gomes
Förderung
- Fundação para a Ciência e Tecnologia
- Direção Regional da Ciência e Tecnologia, Governo Regional dos Açores
- strategic program UID/BIA/04050/2020 funded by National funds through the Fundação para a Ciência e Tecnologia I.P.
Zitieren
APA
Ribeiro, J., Lopes, I., & Gomes, A. C. (2023). A New Perspective for the Treatment of Alzheimer’s Disease: Exosome-like Liposomes to Deliver Natural Compounds and RNA Therapies. Molecules, 28(16), 6015. https://doi.org/10.3390/molecules28166015
Vancouver
Ribeiro J, Lopes I, Gomes AC. A New Perspective for the Treatment of Alzheimer’s Disease: Exosome-like Liposomes to Deliver Natural Compounds and RNA Therapies. Molecules. 2023;28(16):6015. doi:10.3390/molecules28166015
BibTeX
@article{Ribeiro2023,
author = {Ribeiro, Joana and Lopes, Ivo and Gomes, Andreia Castro},
title = {A New Perspective for the Treatment of Alzheimer’s Disease: Exosome-like Liposomes to Deliver Natural Compounds and RNA Therapies},
journal = {Molecules},
year = {2023},
volume = {28},
number = {16},
pages = {6015},
doi = {10.3390/molecules28166015}
}
EUVIMED